InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: NASDAQ2020 post# 152200

Friday, 04/24/2015 3:50:14 PM

Friday, April 24, 2015 3:50:14 PM

Post# of 400048
Blood and Urine analyses are very valuable information for both FDA and $ELTP. The HAL studies would have been also reviewing Blood and Urine analyses and ADT labeling granted accordingly.

In addition $ELTP on its own will correctly state to the FDA that their other Agonists, such as Morphine, Hydrocodone etc. would behave exactly the same way as the Oxycodone ER polymer is the same. The different Agonists have no reaction whatsoever with the ER polymer. As for the Antagonist Sequestering Polymer it is always the same for the Naltrexone.

Blood and Urine analyses monies for the 165 persons P3 Pain Efficacy trial will be well spent by $ELTP and IMO lead to quicker FDA approval for $ELTP's other Agonists ADTs.

With several Blood and Urine analyses, the FDA and $ELTP will know exactly (1) the exact amount of Oxycodone dosed and (2)the exact amount of Naltrexone leaked. These are extremely valuable information in judging $ELTP ADT delivery systems.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News